Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...

Is BioMarin stock a bargain or a falling knife? Learn about key issues affecting its investment prospects and potential for recovery.

Ascentage Pharma Group said its American depositary shares were slated to begin trading on the Nasdaq Global Market on Friday, with its initial public offering priced at $17.25 per ADS.

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Highlights:,Tevogen Bio,(NASDAQ:TVGN),shared insights on AI-driven drug development at the J.P. Morgan Healthcare Conference.

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

NEW YORK, Jan. 27, 2025 /PRNewswire/ -- J.P. Morgan Asset Management today released its seventh annual Global Alternatives Outlook, providing a 12-to-18 month outlook across key alternative asset ...

GameOn founder Alexander Beckman and wife Victoria Lau Beckman bought San Francisco homes with stolen funds, property records ...